A scientist-turned-biotech executive is notching some wins, and enjoying it

Greg Verdine sees a lot of planted seeds bearing fruit at RevMed, Parabilis, and LifeMine

Scientist and biotech executive Greg VerdinePhoto illustration: STAT; photo: Courtesy LifeMine Therapeutics

Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis.01.

Greg Verdine is having a very good year.

The scientist-turned-biotech entrepreneur has been basking in the knowledge that the science he had tried to propel forward nearly 15 years ago may have changed the landscape for pancreatic cancer patients.